home All News open_in_new Full Article

Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder

– EMBRACE, the second Phase 3 study within the PARADIGM program, expects to enroll 330 participants at approximately 60 clinical sites across the United States, Europe and Australia and will commence imminently – – PARADIGMTM comprises two 12-week randomized, double-blind, placebo-controlled studies (APPROACH® and EMBRACE®) and a long-term extension study (EXTEND), with anticipated combined enrollment […]


today 12 h. ago attach_file Politics

attach_file Economics
attach_file Culture
attach_file Society
attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Politics
attach_file Other
attach_file Politics
attach_file Science
attach_file Other
attach_file Other
attach_file Politics
attach_file Science
attach_file Politics
attach_file Sport
attach_file Transport
attach_file Economics
attach_file Culture


ID: 923556507
Add Watch Country

arrow_drop_down